Predictive biomarkers of disease progression in idiopathic pulmonary fibrosisReview Article Published on 2023-12-112024-09-05 Journal: Heliyon [Category] update2024, [키워드] Biomarkers Gender-age-physiology HRCT Idiopathic pulmonary fibrosis [DOI] 10.1016/j.heliyon.2023.e23543 PMC 바로가기 [Article Type] Review Article
Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs항염증제 및 항바이러스제 치료를 받는 간질성 폐질환 환자의 코로나19 결과Article Published on 2022-07-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] 치료제, [키워드] Affect age and sex anti-inflammatory drug antiviral drug antiviral drugs Antiviral treatment coronavirus disease Coronavirus disease 2019 Corticosteroid corticosteroid therapy Corticosteroids COVID-19 COVID-19 patient COVID-19 patients death Diagnosis evaluate Favipiravir fibrosis honeycomb lung HRCT Idiopathic pulmonary fibrosis ILD immunosuppressive agent Immunosuppressive agents increased risk Interstitial lung disease interstitial pneumonia lung Lung disease medical record medical records mortality rate no statistical difference outcome Patient patients treated patients with COVID-19 proportion pulmonary fibrosis Remdesivir reported risk factor Risk factors selected severe disease Severe patient severe patients treated Univariate analysis [DOI] 10.1016/j.jiac.2022.04.006 PMC 바로가기 [Article Type] Article
A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from AfricaClinical Trial Published on 2022-07-012022-10-05 Journal: PLoS ONE [Category] 임상, [키워드] 24 hour absence benefit cellular proliferation clinical benefit clinical trial Complete condition conducted COVID-19 CRP Cytokine storm D-dimer Day death defined demonstrated died discharge discharged dose Efficacy elevated enrolled feasibility feasible fraction High-resolution HRCT identify Inflammatory marker inhibit investigator-initiated Kenya low dose lung management mechanical ventilation median time on mechanical ventilation oxygen Oxygen requirement Oxygenation Patient patients PCR Pneumonia polymerase chain primary endpoint progressed radiation therapy remained resources SAE Safe secondary endpoint Sepsis severe COVID-19 Severe COVID-19 pneumonia the patient therapy Toxicity treat treated Treatment Trial university Vaccine were excluded [DOI] 10.1371/journal.pone.0270594 PMC 바로가기 [Article Type] Clinical Trial
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, IndiaRandomized Controlled Trial Published on 2022-06-012022-10-04 Journal: Complementary therapies in medicine [Category] COVID19(2023년), SARS, 신약개발, 임상, [키워드] Adverse Analysis Ayurveda Care Chest clinical recovery conducted contributed control group COVID COVID-19 determine diagnosed disease double-blind drug effective Efficacy Final HRCT incidence India integrative medicine less metabolic functions Mild moderate Moderate COVID-19 negative RT-PCR Open-label outcome pandemic parallel-group participant Participants Patient pro-inflammatory proportion Proportion of participant Randomized Randomized controlled trial reaction reported Safe Significant significantly standard care Tablet therapeutic efficacy Trial trials two groups viral disease [DOI] 10.1016/j.ctim.2022.102814 PMC 바로가기 [Article Type] Randomized Controlled Trial
Should Thorax Thin-Section Computed Tomography Be a Standard Diagnostic Procedure in the Evaluation of Potential Kidney Transplant Recipients? Lessons Learned From the COVID-19 PandemicResearch article Published on 2022-05-012022-10-05 Journal: Transplantation proceedings [Category] 진단, [키워드] accounted Allograft blood chemistry comorbid condition Comorbidity Computed tomography COVID-19 COVID-19 pandemic COVID-19 symptom COVID‐19 Deceased Department dialysis Donor End-stage renal disease evaluate evaluated HRCT kidney kidney transplant kidney transplant recipient kidney transplant recipients lesson Lungs pandemic Patient patient population Poland polymerase chain Potential procedure recipients Result Standard surgery tested transcriptase Transplant Treatment university Warsaw was performed [DOI] 10.1016/j.transproceed.2022.03.044 [Article Type] Research article
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up studyObservational Study Published on 2022-03-212022-10-05 Journal: Respiratory Research [Category] 임상, [키워드] caused chest HRCT collected Computed tomography COVID-19 Diagnosis diffusion capacity discharge Dyspnea evaluated Follow-up follow-up study groups high resolution High resolution computed tomography (HRCT) high resolution CT higher risk hospitalised Hospitalization HRCT identify impairment IMV interstitial lung abnormalities lung abnormality Lung disease mechanical ventilation Medical Research Council Mild mMRC multicenter multicentre no difference older patient Patient patients patients hospitalized Pneumonia positive airway pressure pulmonary pulmonary fibrosis Pulmonary function test pulmonary impairment radiological reported SARS-CoV-2 pneumonia stratified ventilatory support [DOI] 10.1186/s12931-022-01994-y PMC 바로가기 [Article Type] Observational Study
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary EmbolismMolecular Biosciences Published on 2022-02-032022-10-31 Journal: Frontiers in Molecular Biosciences [Category] COVID-19, [키워드] 6MWT abnormality addition adult COVID-19 patient carried chronic lung disease clinical history complication of COVID-19 Computed tomography conducted COVID - 19 COVID-19 COVID-19 patient demonstrated Diagnosis diffusion capacity DLCO Dyspnoea Embolism evaluated Exercise capacity feature Follow-up functional consequence High-resolution HRCT impairment KCO lung Lung function mMRC Month Patient Pneumonia predicted previous study pulmonary pulmonary angiography Pulmonary embolism Pulmonary function Pulmonary function test Respiratory function retrospective significant difference significantly lower six minute walk test spirometry subject the patient those without PE were excluded [DOI] 10.3389/fmolb.2021.809186 PMC 바로가기 [Article Type] Molecular Biosciences
Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 PneumoniaMedicine Published on 2022-01-312022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Admission alveolar Analysis analyzed Computed tomography consecutive patient consolidation Coronavirus disease 2019 COVID-19 COVID-19 infection discharge disease evaluated Factor Follow-up ground-glass opacity High-resolution high-resolution computed tomography Hospital admission Hospital stay Hospitalization HRCT In-hospital independent predictor initial interstitial lung abnormality men Older P/F Patient patients persistence Pneumonia predict predictor pulmonary pulmonary fibrosis pulmonary sequelae radiological radiological abnormality REC Result SARS-CoV-2 semiquantitatively [DOI] 10.3389/fmed.2021.823600 PMC 바로가기 [Article Type] Medicine
Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial경증에서 중등도의 증상을 보이는 SARS-CoV-2 감염 환자에서 요오드 복합체의 임상 효능: 무작위 대조 시험을 위한 연구 프로토콜Update Published on 2022-01-192022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] adaptive addition alleviate analyzed Arm benefit both groups caused Chest clinic clinical clinical trial collected Combination complex Computed tomography conducted coronavirus disease Coronavirus disease 2019 Coronavirus-2 country COVID-19 COVID-19 patient COVID-19 patients doctor Efficacy High-resolution Hospitalization HRCT implication IMPROVE in both groups Intervention Iodine lower mortality Mild mild to moderate mild to moderate symptoms moderate Mortality Novel coronavirus pandemic parallel group parameter Patient Placebo placebo-controlled Polymer questionnaire radiological improvement Randomized controlled trial randomized trial receive reduction in respiratory respiratory syndrome coronavirus RT-PCR Sample size SARS-CoV-2 SARS-CoV-2-infected patient SAS version 9.4 severe respiratory syndrome socioeconomic status standard care Study protocol symptomatic Symptoms syrup Treatment treatment of COVID-19 Trial Trial registration Viral Viral load viral load reduction with COVID-19 written consent [DOI] 10.1186/s13063-021-05848-8 PMC 바로가기 [Article Type] Update
Integrative management of critical case of Covid 19 with Ayurveda and modern medicine: A case reportCase report Published on 2022-01-012022-10-05 Journal: Journal of Ayurveda and Integrative Medicine [Category] 신약개발, [키워드] age Ayurveda breathlessness Case report clinical symptom cough COVID 19 Critical Critical case dropped Health HRCT Hypothyroidism ICU Immunity integrative medicine intensive care male management medication Medicine oxygen pandemic Patient PCR performed positive provide raised Research respiratory rate Significant thalassemia treated Treatment Treatment protocol [DOI] 10.1016/j.jaim.2021.07.012 [Article Type] Case report